Guardant Health's performance is under scrutiny as it faces comparisons with competitor Grail.
A recent article comparing Guardant Health Inc. (GH) to Grail has prompted investors to evaluate which stock might be a better buy. Guardant Health closed at US$167.31, down 1.65% on the day, and has seen a decline of 5.26% over the past week. Year-to-date, however, the stock remains up 62.73%.
Advertisement
Guardant Health Inc
GH.US
GH.US
Guardant Health Inc
WealthAwesomeMarket cap
$22.22B
52W high
$191.05
52W low
$61.00
1W change
-5.26%
Beta
1.58
Analyst Price Targets
Based on analyst covering GH · as of Oct 9, 2026
Wall Street analysts forecast GH stock price to rise 1367.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$200.24
+1367.0% Upside
Previously C$199.84 on Oct 7, 2026
Current Price
C$13.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GH's historical volatility
30-Day Vol
48.3%
Annualized
90-Day Vol
52.0%
Annualized
Trend (90d)
+6.6%
Annualized drift
90d Mean
C$169.54
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$166.88 | C$141.25 – C$197.15 |
| 60 trading days | C$168.20 | C$132.87 – C$212.93 |
| 90 trading days | C$169.54 | C$127.02 – C$226.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Guardant Health's financial health and trading activity warrant careful consideration amid market comparisons.
Guardant Health Closes at $167.31 with 809,024 Shares Traded
Trading volume for Guardant Health was 809,024 shares, below its 20-day average of 1,922,771 shares, indicating a decrease in trading activity.
Bull case
Guardant Health has a market cap of over $22 billion. Analysts have set an average target price of US$200.24, which suggests a potential upside of 19.7% from its current price.
Bear case
However, the company is facing significant challenges with a profit margin of -38.3% and an alarming return on equity (ROE) of -4584.5%. These figures raise serious concerns about its long-term viability.
Performance Overview Amid Competitive Analysis
Advertisement
Guardant Health's stock closed at US$167.31, reflecting a decline of 1.65% for the day and a decrease of 5.26% over the past week. Despite these short-term challenges, the stock has appreciated by 62.73% year-to-date. The 52-week trading range for the stock is US$61.00 to US$191.05, indicating that it is currently positioned at approximately 82% of its range. This performance has drawn investor attention as it compares to Grail.
Volume and Trading Activity
The trading volume for Guardant Health was recorded at 809,024 shares, significantly lower than its 20-day average volume of 1,922,771 shares, which is only 0.83 times the average. This indicates a decrease in investor activity around the stock, which could be a factor as comparisons with Grail unfold. Additionally, Guardant Health's price is slightly below its 50-day moving average of US$167.56, positioning it for potential volatility in the coming days.
Financial Metrics Under Scrutiny
Guardant Health's financials reveal a profit margin of -38.3% and a return on equity (ROE) of -4584.5%, raising concerns about its profitability and overall financial health. The company's earnings per share (EPS) stands at -3.5, reflecting ongoing challenges in generating profits. Analysts are bullish, with an average target price of US$200.24, implying a potential upside of 19.7%. However, the negative financial metrics may lead investors to exercise caution.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
